Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,750.00
Ask: 2,222.00
Change: 0.00 (0.00%)
Spread: 472.00 (26.971%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,958.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up

Wed, 24th Oct 2012 09:25

African Barrick Gold: Investec raises target from 485p to 530p, hold rating kept.Aggreko: Seymour Pierce maintains buy rating and 2,500p target.AstraZeneca: Panmure Gordon keeps hold rating and 3,000p target.British American Tobacco: Jefferies keeps buy rating and 3,730p target; Panmure Gordon cuts target from 3,700p to 3,650p, buy rating kept; Investec keeps buy rating and 3,480p target.Centamin: Investec downgrades from buy to hold, target lifted from 95p to 106p.CRH: AlphaValue upgrades from add to buy.CSR: JPMorgan Cazenove downgrades to neutral; UBS ups target from 310p to 330p, neutral rating kept.Diamondcorp: WH Ireland Securities initiates coverage with buy rating and 12p target.Direct Line: JPMorgan Cazenove initiates coverage with neutral rating and 197p target.Experian: Jefferies downgrades from buy to hold, target upped from 1,060p to 1,200p; UBS raises target from 970p to 1,040p, neutral rating kept.Fidessa: Goldman Sachs downgrades to neutral, target cut from 2,050p to 1,580p.Hikma: Jefferies ups target from 875p to 890p, buy rating kept.Home Retail: Panmure Gordon hikes target from 51p to 80p, sell rating kept; Panmure Gordon keeps buy rating and 115p target.HSBC: Investec keeps hold rating and 590p target.Imperial Tobacco: Goldman Sachs upgrades to neutral, target cut from 2,540p to 2,500p.InterContinental Hotels: AlphaValue upgrades from reduce to add; Panmure Gordon keeps hold rating and 1,670p target.National Express: Jefferies maintains buy rating and 300p target; Panmure Gordon keeps hold rating and 250p target.Next: Panmure Gordon ups target from 3,743p to 3,770p, hold rating kept.Ophir Energy: Jefferies keeps buy rating and 800p target.Punch Taverns: Panmure Gordon cuts target from 11p to 7p, hold rating kept.Randgold Resources: Investec downgrades from buy to hold, target lifted from 6,917p to 7,715p.Regus: Panmure Gordon keeps buy rating and 140p target.Spirent Communications: Investec keeps buy rating and 195p target.Sports Direct: Panmure Gordon raises target from 350p to 450p, buy rating kept.Tesco: AlphaValue downgrades from buy to add.Travis Perkins: Panmure Gordon keeps buy rating and 1,200p target.Trinity Mirror: Panmure Gordon keeps buy rating and 90p target.Wolseley: Jefferies keeps hold rating and 2,340p target.WPP: UBS downgrades from buy to neutral, target cut from 960p to 875p.BC
More News
27 Feb 2024 09:40

Berenberg slightly raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,960.0p to 2,000.0p on Tuesday, citing more stability in its generics unit.

Read more
23 Feb 2024 09:19

LONDON BROKER RATINGS: Barclays raises Breedon but cuts Domino's Pizza

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
22 Feb 2024 16:26

London close: Stocks rise amid raft of solid earnings

(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.

Read more
22 Feb 2024 09:49

LONDON BROKER RATINGS: Berenberg raises Moneysupermarket.com to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
22 Feb 2024 09:42

TOP NEWS: Hikma boosts dividend after year of "significant progress"

(Alliance News) - Shares in Hikma Pharmaceuticals PLC jumped on Thursday after it lifted the dividend by 29% amid better-than-expected annual profit.

Read more
22 Feb 2024 07:51

Hikma lifts dividend after double-digit growth in 2023

(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Feb 2024 07:23

Hikma agrees to settle US opioid claims

(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.

Read more
1 Feb 2024 20:00

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 09:29

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

Read more
20 Dec 2023 09:25

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Dec 2023 09:11

LONDON BROKER RATINGS: Peel Hunt raises Flutter to 'buy' from 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 13:08

Jefferies downgrades Hikma to 'hold'

(Sharecast News) - Jefferies downgraded Hikma Pharmaceuticals on Tuesday to 'hold' from 'buy' and cut the price target to 1,940p from 2,125p.

Read more
7 Nov 2023 09:28

LONDON BROKER RATINGS: Watches of Switzerland impresses HSBC; Asos cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.